Download PDF
Am J Perinatol 2024; 41(S 01): e2356-e2364
DOI: 10.1055/a-2113-8621
Review Article

Superior Vena Cava Flow in Preterm Infants and Neonatal Outcomes: A Systematic Review

Bishal Gautam
1   Department of Pediatrics, University of Alberta, Alberta, Canada
2   Alberta Health Services, Edmonton, Canada
,
Aimann Surak
1   Department of Pediatrics, University of Alberta, Alberta, Canada
2   Alberta Health Services, Edmonton, Canada
,
Sandra M. Campbell
3   John W. Scott Health Sciences Library, University of Alberta, Edmonton, Canada
,
Manoj Kumar 
1   Department of Pediatrics, University of Alberta, Alberta, Canada
2   Alberta Health Services, Edmonton, Canada
› Author Affiliations
Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Superior vena cava (SVC) flow has been considered a surrogate marker of systemic blood flow in neonates. We conducted a systematic review to evaluate the association between low SVC flow recorded during the early neonatal period and neonatal outcomes. We searched the following databases (until December 9, 2020; updated October 21, 2022): PROSPERO, OVID Medline, OVID EMBASE, Cochrane Library (CDSR and Central), Proquest Dissertations and Theses Global, and SCOPUS using controlled vocabulary and key words representing the concepts “superior vena cava” and “flow” and “neonate.” Results were exported to COVIDENCE review management software. The search retrieved 593 records after the removal of duplicates, of which 11 studies (nine cohorts) met the inclusion criteria. The majority of the studies included infants born at <30 weeks of gestation. The included studies were assessed as high risk of bias in terms of the incomparability of the study groups, with infants in the low SVC flow group noted to be more immature than those in the normal SVC flow group or subjected to different cointerventions. We did not conduct meta-analyses in view of the significant clinical heterogeneity noted in the included studies. We found little evidence to suggest that SVC flow in the early neonatal period is an independent predictor for adverse clinical outcomes in preterm infants. Included studies were assessed at high risk of bias. We conclude that SVC flow interpretation for prognostication or for making treatment decisions should be restricted to the research setting for now. We highlight the need for strengthened methods in future research studies.

Key Points

  • We studied whether low SVC flow in the early neonatal period is a marker for adverse outcomes in preterm infants.

  • There is insufficient evidence to conclude that low SVC flow is a valid predictor of adverse outcomes.

  • There is insufficient evidence to conclude that SVC flow-directed hemodynamic management improves clinical outcomes.

Keywords

SVC flow - newborn - intraventricular hemorrhage - systematic review

Authors' Contributions

The manuscript has been read and approved by all the authors that the requirements for authorship have been met and that each author believes that the manuscript represents honest work.


Supplementary Material



Publication History

Received: 25 January 2023

Accepted: 19 June 2023

Accepted Manuscript online:
20 June 2023

Article published online:
24 July 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Kluckow M, Evans N. Superior vena cava flow in newborn infants: a novel marker of systemic blood flow. Arch Dis Child Fetal Neonatal Ed 2000; 82 (03) F182-F187
    CrossrefPubMedSearch in Google Scholar
  • 2 Calbet JA, Gonzalez-Alonso J, Helge JW. et al. Cardiac output and leg and arm blood flow during incremental exercise to exhaustion on the cycle ergometer. J Appl Physiol 2007; 103 (03) 969-978
    CrossrefPubMedSearch in Google Scholar
  • 3 de Waal KA. The methodology of Doppler-derived central blood flow measurements in newborn infants. Int J Pediatr 2012; 2012: 680162
    CrossrefPubMedSearch in Google Scholar
  • 4 McGovern M, Miletin J. A review of superior vena cava flow measurement in the neonate by functional echocardiography. Acta Paediatr 2017; 106 (01) 22-29
    CrossrefPubMedSearch in Google Scholar
  • 5 Kluckow M, Evans N. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed 2000; 82 (03) F188-F194
    CrossrefPubMedSearch in Google Scholar
  • 6 Bates S, Odd D, Luyt K. et al. Superior vena cava flow and intraventricular haemorrhage in extremely preterm infants. J Matern Fetal Neonatal Med 2016; 29 (10) 1581-1587
    CrossrefPubMedSearch in Google Scholar
  • 7 Miletin J, Dempsey EM. Low superior vena cava flow on day 1 and adverse outcome in the very low birthweight infant. Arch Dis Child Fetal Neonatal Ed 2008; 93 (05) F368-F371
    CrossrefPubMedSearch in Google Scholar
  • 8 Kluckow M, Evans N. Low systemic blood flow and hyperkalemia in preterm infants. J Pediatr 2001; 139 (02) 227-232
    CrossrefPubMedSearch in Google Scholar
  • 9 Cerbo RM, Orcesi S, Scudeller L. et al. Near-infrared spectroscopy monitoring, superior vena cava flow, and neurodevelopmental outcome at 2 years in a cohort of very low-birth-weight infants. Am J Perinatol 2016; 33 (11) 1093-1098
    Thieme ConnectPubMedSearch in Google Scholar
  • 10 Osborn DA, Evans N, Kluckow M, Bowen JR, Rieger I. Low superior vena cava flow and effect of inotropes on neurodevelopment to 3 years in preterm infants. Pediatrics 2007; 120 (02) 372-380
    CrossrefPubMedSearch in Google Scholar
  • 11 Popat H, Robledo KP, Kirby A. et al. Associations of measures of systemic blood flow used in a randomized trial of delayed cord clamping in preterm infants. Pediatr Res 2019; 86 (01) 71-76
    CrossrefPubMedSearch in Google Scholar
  • 12 Stroup DF, Berlin JA, Morton SC. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283 (15) 2008-2012
    CrossrefPubMedSearch in Google Scholar
  • 13 Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Accessed May 29, 2023 at: https://www.covidence.org
    PubMed
  • 14 Wells G, Shea B, O'Connell D, Peterson J. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, ON: Ottawa Hospital Research Institute. Accessed May 29, 2023 at: https://www.ohri.ca/programs/clinical_epidemiology/nosgen.pdf
    PubMed
  • 15 Dekkers OM, Vandenbroucke JP, Cevallos M, Renehan AG, Altman DG, Egger M. COSMOS-E: guidance on conducting systematic reviews and meta-analyses of observational studies of etiology. PLoS Med 2019; 16 (02) e1002742
    CrossrefPubMedSearch in Google Scholar
  • 16 Osborn DA, Evans N, Kluckow M. Clinical detection of low upper body blood flow in very premature infants using blood pressure, capillary refill time, and central-peripheral temperature difference. Arch Dis Child Fetal Neonatal Ed 2004; 89 (02) F168-F173
    CrossrefPubMedSearch in Google Scholar
  • 17 Osborn DA, Evans N, Kluckow M. Hemodynamic and antecedent risk factors of early and late periventricular/intraventricular hemorrhage in premature infants. Pediatrics 2003; 112 (1 Pt 1): 33-39
    CrossrefPubMedSearch in Google Scholar
  • 18 Meyer MP, Mildenhall L. Delayed cord clamping and blood flow in the superior vena cava in preterm infants: an observational study. Arch Dis Child Fetal Neonatal Ed 2012; 97 (06) F484-F486
    CrossrefPubMedSearch in Google Scholar
  • 19 Holberton JR, Drew SM, Mori R, König K. The diagnostic value of a single measurement of superior vena cava flow in the first 24.  h of life in very preterm infants. Eur J Pediatr 2012; 171 (10) 1489-1495
    CrossrefPubMedSearch in Google Scholar
  • 20 Bravo MC, López-Ortego P, Sánchez L. et al. Randomized, placebo-controlled trial of dobutamine for low superior vena cava flow in infants. J Pediatr 2015; 167 (03) 572-8.e1, 2
    CrossrefPubMedSearch in Google Scholar
  • 21 Bravo MC, López-Ortego P, Sánchez L, Díez J, Cabañas F, Pellicer A. Randomised trial of dobutamine versus placebo for low superior vena cava flow in preterm infants: long-term neurodevelopmental outcome. J Paediatr Child Health 2021; 57 (06) 872-876
    CrossrefPubMedSearch in Google Scholar
  • 22 Farag MM, Gouda MH, Almohsen AMA, Khalifa MA. Intraventricular hemorrhage prediction in premature neonates in the era of hemodynamics monitoring: a prospective cohort study. Eur J Pediatr 2022; 181 (12) 4067-4077
    CrossrefPubMedSearch in Google Scholar
  • 23 Osborn D, Evans N, Kluckow M. Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr 2002; 140 (02) 183-191
    CrossrefPubMedSearch in Google Scholar
  • 24 Paradisis M, Evans N, Kluckow M, Osborn D. Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. J Pediatr 2009; 154 (02) 189-195
    CrossrefPubMedSearch in Google Scholar
  • 25 Ficial B, Bonafiglia E, Padovani EM. et al. A modified echocardiographic approach improves reliability of superior vena caval flow quantification. Arch Dis Child Fetal Neonatal Ed 2017; 102 (01) F7-F11
    CrossrefPubMedSearch in Google Scholar